Kinderonkologie: Erhaltungspflege von Broviac- und Port-Kathetern

Max Scheler; Arne Simon

doi:10.1055/s-0042-123726

Krankenhaushygiene up2date, Table of Contents

Krankenhaushygiene up2date 2017; 12(01): 43-56
DOI: 10.1055/s-0042-123726

Präventionsmaßnahmen

Kinderonkologie: Erhaltungspflege von Broviac- und Port-Kathetern

Authors

Max Scheler
Arne Simon

Abstract

All articles of this category

Die meisten Kinder mit Krebs erhalten zu Beginn der Chemotherapie einen zentralen Venenkatheter. Die Prävention von Blutstrominfektionen, die von solchen Gefäßkathetern ausgehen, ist ein wichtiges Merkmal guter klinischer Praxis. Dieser Beitrag diskutiert verschiedene Aspekte von Präventionsbündeln in diesem speziellen klinischen Kontext.

Full Text

References

Literaturverzeichnis
1 Adams D, Karpanen T, Worthington T. et al. Infection risk associated with a closed luer access device. J Hosp Infect 2006; 62: 353-357
2 Adler A, Yaniv I, Solter E. et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006; 28: 23-28
3 Adler A, Yaniv I, Steinberg R. et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006; 62: 358-365
4 Allen RC, Holdsworth MT, Johnson CA. et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008; 51: 53-58
5 Ammann RA, Bodmer N, Hirt A. et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 2010; 28: 2008-2014
6 Ammann RA, Hirt A, Luthy AR. et al. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004; 23: 61-67
7 Ammann RA, Laws HJ, Schrey D. et al. Bloodstream infection in paediatric cancer centres-leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015; 174: 675-686
8 Ammann RA, Tissing WJ, Phillips B. Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis 2012; 25: 258-265
9 Arbeitsgruppe KRINKO-BfArM-RKI. Bericht der Arbeitsgruppe KRINKO-BfArM-RKI: Zu spezifischen Fragen bezüglich Rekonstitution, Zubereitung und Applikation von Arzneimitteln und Infusionslösungen sowie zur Hautantiseptik. Berlin: Epidemiol Bulletin des Robert Koch-Instituts; 2016. Nr. 20 173-178
10 Austin PD, Elia M. A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments. J Pharm Pharm Sci 2009; 12: 233-242
11 Averbuch D, Cordonnier C, Livermore DM. et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 2013; 98: 1836-1847
12 Averbuch D, Orasch C, Cordonnier C. et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013; 98: 1826-1835
13 Barrell C, Covington L, Bhatia M. et al. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients. Am J Infect Control 2012; 40: 434-439
14 Bass P, Karki S, Rhodes D. et al. Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients. Am J Infect Control 2013; 41: 345-348
15 Berrueco R, Rives S, Catala A. et al. Prospective Surveillance Study of Blood Stream Infections Associated With Central Venous Access Devices (Port-type) in Children With Acute Leukemia: An Intervention Program. J Pediatr Hematol Oncol 2013; 35: e194-e199
16 Bertoglio S, Rezzo R, Merlo FD. et al. Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. J Hosp Infect 2013; 84: 85-88
17 Bishay M, Retrosi G, Horn V. et al. Chlorhexidine antisepsis significantly reduces the incidence of sepsis and septicemia during parenteral nutrition in surgical infants. J Pediatr Surg 2011; 46: 1064-1069
18 Bisseling TM, Willems MC, Versleijen MW. et al. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2010; 29: 464-468
19 Biwersi C, Hepping N, Bode U. et al. Bloodstream infections in a German paediatric oncology unit: Prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health 2009; 212: 541-546
20 Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000; 25: 1269-1278
21 Bosk CL, Dixon-Woods M, Goeschel CA. et al. Reality check for checklists. Lancet 2009; 374: 444-445
22 Bradshaw JH, Puntis JW. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Pediatr Gastroenterol Nutr 2008; 47: 179-186
23 Bundy DG, Gaur AH, Billett AL. et al. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics 2014; 134: e1678-e1685
24 Cheng S, Teuffel O, Ethier MC. et al. Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia. Br J Cancer 2011; 105: 606-611
25 Chesshyre E, Goff Z, Bowen A. et al. The prevention, diagnosis and management of central venous line infections in children. J Infect 2015; 71 (Suppl. 01) 59-75
26 Choi SW, Chang L, Hanauer DA. et al. Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods. Pediatr Blood Cancer 2013; 60: 262-269
27 Chu HP, Brind J, Tomar R. et al. Significant Reduction in Central Venous Catheter-related Bloodstream Infections in Children on HPN After Starting Treatment With Taurolidine Line Lock. J Pediatr Gastroenterol Nutr 2012; 55: 403-407
28 Climo MW, Yokoe DS, Warren DK. et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533-542
29 Cullis PS, McKee RF. Taurolidine lock - experience from the West of Scotland. Clin Nutr 2011; 30: 399-400
30 Deutsche Gesellschaft für pädiatrische Infektiologie (DGPI), Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Diagnostik und Therapie bei Kindern mit onkologischer Grunderkrankung, Fieber und Granulozytopenie (mit febriler Neutropenie) außerhalb der allogenen Stammzelltransplantation. Arbeitsgemeinschaft Wissenschaftlicher Fachgesellschaften (AWMF); 2016 Registernummer 048/14
31 Diorio C, Martino J, Boydell KM. et al. Parental perspectives on inpatient versus outpatient management of pediatric febrile neutropenia. J Pediatr Oncol Nurs 2011; 28: 355-362
32 Duffy EA, Rodgers CC, Shever LL. et al. Implementing a Daily Maintenance Care Bundle to Prevent Central Line-Associated Bloodstream Infections in Pediatric Oncology Patients. J Pediatr Oncol Nurs 2015; 32: 394-400
33 Ellger B, Kiski D, Diem E. et al. Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions. J Hosp Infect 2011; 78: 31-35
34 Engelhart S, Exner M, Simon A. In vitro study on the disinfectability of two split-septum needle-free connection devices using different disinfection procedures. GMS hygiene and infection control 2015; 10 Doc17
35 Furtwangler R, Laux C, Graf N. et al. Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients. GMS hygiene and infection control 2015; 10 Doc15
36 Gastmeier P, Kampf KP, Behnke M. et al. An observational study of the universal use of octenidine to decrease nosocomial bloodstream infections and MDR organisms. J Antimicrob Chemother 2016; 71: 2569-2576
37 Gaur AH, Bundy DG, Gao C. et al. Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol 2013; 34: 316-320
38 Gyssens IC, Kern WV, Livermore DM. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica 2013; 98: 1821-1825
39 Handrup MM, Moller JK, Frydenberg M. et al. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55: 309-313
40 Helm RE, Klausner JD, Klemperer JD. et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs 2015; 38: 189-203
41 Herbig S, Kaiser V, Maurer J. et al. ADKA-Leitlinie: Aseptische Herstellung und Prüfung applikationsfertiger Parenteralia. Krankenhauspharmazie 2013; 34: 93-106
42 Holroyd JL, Paulus DA, Rand KH. et al. Universal intravenous access cleaning device fails to sterilize stopcocks. Anesth Analg 2014; 118: 333-343
43 Hong H, Morrow DF, Sandora TJ. et al. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity. Am J Infect Control 2013; 41: e77-e79
44 Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332
45 Horvath B, Norville R, Lee D. et al. Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum 2009; 36: 232-238
46 Huang SS, Septimus E, Kleinman K. et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255-2265
47 Hubner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23: 244-258
48 Ivy DD, Calderbank M, Wagner BD. et al. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension. Infect Control Hosp Epidemiol 2009; 30: 823-829
49 Jack T, Boehne M, Brent BE. et al. In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med 2012; 38: 1008-1016
50 Jack T, Brent BE, Boehne M. et al. Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit. Intensive Care Med 2010; 36: 707-711
51 Jurewitsch B, Jeejeebhoy KN. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr 2005; 24: 462-465
52 Jurewitsch B, Lee T, Park J. et al. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998; 22: 242-244
53 Kelly M, Conway M, Wirth K. et al. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol 2011; 32: 1079-1085
54 Kelly MJ, Vivier PM, Panken TM. et al. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer 2010; 54: 83-87
55 Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (KRINKO). Empfehlungen zu den Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2010; 53: 357-388
56 Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (KRINKO). Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsbl - Gesundheitsforsch – Gesundheitsschutz 2014; 57: 696-732
57 Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (KRINKO). Empfehlungen zur Händehygiene in Einrichtungen des Gesundheitswesens. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2016; 59: 1189-1220
58 Krenn T, Fleischhack G, Moser O. et al. Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals. Klin Padiatr 2011; 223: 335-340
59 Lehrnbecher T, Phillips R, Alexander S. et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation. J Clin Oncol 2012; 30: 4427-4438
60 Liu H, Liu H, Deng J. et al. Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood purification 2014; 37: 179-187
61 Lockman JL, Heitmiller ES, Ascenzi JA. et al. Scrub the hub! Catheter needleless port decontamination. Anesthesiology 2011; 114: 958
62 Lopez-Briz E, Ruiz-Garcia V. [Effectiveness of heparin versus NaCl 0.9% in central venous catheter flushing. A systematic review]. Farm Hosp 2005 29: 258-264
63 Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: Old Foe, Emerging Threat. Clin Infect Dis 2015; 60
64 Maragakis LL, Bradley KL, Song X. et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27: 67-70
65 Marschall J, Mermel LA, Fakih M. et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35: 753-771
66 McMullan C, Propper G, Schuhmacher C. et al. A multidisciplinary approach to reduce central line-associated bloodstream infections. Jt Comm J Qual Patient Saf 2013; 39: 61-69
67 Meckler G, Lindemulder S. Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am 2009; 27: 525-544
68 Miedema KG, Winter RH, Ammann RA. et al. Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns. Support Care Cancer 2013; 21: 2417-2426
69 Miller MR, Griswold M, Harris JM. et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010; 125: 206-213
70 Miller MR, Niedner MF, Huskins WC. et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011; 128: e1077-1083
71 Milstone AM, Elward A, Song X. et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013; 381: 1099-1106
72 Pohl F, Hartmann W, Holzmann T. et al. Risk of infection due to medical interventions via central venous catheters or implantable venous access port systems at the middle port of a three-way cock: luer lock cap vs. luer access split septum system (Q-Syte). BMC Infect Dis 2014; 14: 41
73 Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol 2000; 21: 260-263
74 Reichardt C, Koniger D, Bunte-Schonberger K. et al. Three years of national hand hygiene campaign in Germany: what are the key conclusions for clinical practice?. J Hosp Infect 2013; 83 (Suppl. 01) S11-S16
75 Rinke ML, Bundy DG, Chen AR. et al. Central line maintenance bundles and CLABSIs in ambulatory oncology patients. Pediatrics 2013; 132: e1403-e1412
76 Rinke ML, Chen AR, Bundy DG. et al. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics 2012; 130: e996-e1004
77 Samet A, Sledzinska A, Krawczyk B. et al. Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis 2013; 32: 1393-1400
78 Sammons JS, Localio R, Xiao R. et al. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013; 57: 1-8
79 Sannoh S, Clones B, Munoz J. et al. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control 2010; 38: 424-429
80 Scheithauer S, Lewalter K, Schroder J. et al. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection 2014; 42: 155-159
81 Schlicht A, Fleischhack G, Herdeis C. et al. In vitro investigation of the exposure time necessary to yield a 5 log reduction of clinicall relevant bacteria by a taurolidine containing antimicrobial catheter lock solution. Hygiene & Medizin 2009; 34: 343-345
82 Shah CB, Mittelman MW, Costerton JW. et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46: 1674-1679
83 Simon A, Ammann RA, Bode U. et al. Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 University hospitals in Germany and Switzerland. BMC Infect Dis 2008; 70
84 Simon A, Beutel K, Trautmann M. et al. Evidenzbasierte Empfehlungen zur Anwendung dauerhaft implantierter, zentralvenöser Zugänge in der pädiatrischen Onkologie. 4. Aufl. Wiesbaden: mhp; 2013
85 Simon A, Fleischhack G, Hasan C. et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592-596
86 Simon A, Furtwangler R, Graf N. et al. Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on?. GMS hygiene and infection control 2016; 11 Doc11
87 Simon A, Graf N, Furtwangler R. Results of a Multicentre Survey Evaluating Clinical Practice of Port and Broviac Management in Paediatric Oncology. Klin Padiatr 2013; 225: 145-151
88 Simon A, Groger N, Wilkesmann A. et al. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. Int J Antimicrob Agents 2006; 28: 417-422
89 Smith JS, Kirksey KM, Becker H. et al. Autonomy and Self-efficacy as Influencing Factors in Nursesʼ Behavioral Intention to Disinfect Needleless Intravenous Systems. J Infus Nurs 2011; 34: 193-200
90 Soothill JS, Bravery K, Ho A. et al. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009; 37: 626-630
91 Steinberg JP, Robichaux C, Tejedor SC. et al. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol 2013; 34: 171-175
92 Stucki C, Sautter AM, Favet J. et al. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality. Am J Health Syst Pharm 2009; 66: 2032-2036
93 Tan M, Lau J, Guglielmo BJ. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother 2014; 48: 607-615
94 Teuffel O, Amir E, Alibhai SM. et al. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics 2011; 127: e279-286
95 Tietz A, Frei R, Dangel M. et al. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 2005; 26: 703-707
96 Timsit JF, Mimoz O, Mourvillier B. et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012; 186: 1272-1278
97 Timsit JF, Schwebel C, Bouadma L. et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. Jama 2009; 301: 1231-1241
98 Toure A, Lauverjat M, Peraldi C. et al. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients. Clin Nutr 2012; 31: 567-570
99 Traub WH, Leonhard B, Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993; 39: 322-330
100 Trautmann M, Kreutzberger M, Bobic R. et al. Disinfection of a needleless connector with alcohol-based disinfectant wipes – an experimental study. Hygiene & Medizin 2012; 37: 354-359
101 van der Velden WJ, Herbers AH, Netea MG. et al. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 2014; 167: 441-452
102 Vonberg RP, Gastmeier P. Hospital-acquired infections related to contaminated substances. J Hosp Infect 2007; 65: 15-23
103 Wanten GJA, Bisseling TM. Responding letter to editor - Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2011; 30: 401-401
104 Weichert S, Simon A, von Müller L. et al. Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter. Monatsschrift für Kinderheilkunde 2015; 163: 427-436
105 Weiss K, Simon A, Graf N. et al. Clinical Practice Audit: Perioperative Antibiotic Prophylaxis in Paediatric Cancer Patients with Broviac Catheter Implantation. Klin Padiatr 2016; 228: 139-144
106 Wilson MZ, Rafferty C, Deeter D. et al. Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control 2014; 42: 1157-1160
107 Winters BD, Gurses AP, Lehmann H. et al. Clinical review: checklists - translating evidence into practice. Crit Care 2009; 13: 210
108 Wolf J, Shenep JL, Clifford V. et al. Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer 2013; 60: 18-25
109 Zacharioudakis IM, Zervou FN, Arvanitis M. et al. Antimicrobial Lock Solutions as a Method to Prevent Central Line-Associated Bloodstream Infections: A Meta-analysis of Randomized Controlled Trials. Clin Infect Dis 2014; 59: 1741-1749